Pefloxacin (CAS 70458-92-3) Global Market Research Report 2024

About the Pefloxacin Market

Pefloxacin is an antibiotic used to treat a variety of bacterial infections. It belongs to the fluoroquinolone class of antibiotics, which are used to treat a wide range of bacterial infections. Pefloxacin is effective against both Gram-positive and Gram-negative bacteria, making it a useful tool in the treatment of a variety of infections. It is also used to treat urinary tract infections, respiratory tract infections, and skin and soft tissue infections. Pefloxacin is generally well tolerated, with few side effects. Pefloxacin is available in both oral and intravenous formulations. It is available as a generic drug in many countries, and is also available under various brand names. It is widely used in the treatment of bacterial infections, and is often prescribed as a first-line treatment for many infections. In the market for antibiotics, Pefloxacin is a popular choice due to its broad spectrum of activity and its low cost. It is widely used in both hospital and community settings, and is often prescribed as a first-line treatment for many infections. Some companies in the Pefloxacin market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more